It is telling that GSK, AstraZeneca, Rolls-Royce and Melrose are among the top fallers on the FTSE 100, given they are in the ...

Aston Martin is an iconic FTSE 250 stock that’s been struggling lately. And it looks as though President Trump’s not going to help matters.

We recently published a list of 20 Stocks Insiders Were Selling In Q1 2025. In this article, we are going to take a look at ...

Shares of the conservative network surged over 2,200% after its public debut, despite heavy losses, sparking comparisons to ...

Tariffs' effects on global economies will become more apparent over time, as markets are forward-looking and will react ...

Everyone knows the Browns need a quarterback. But what other position groups should Cleveland be targeting in this year's draft?

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a ...

Fiscal year 2025-26 (FY26), it believes, will likely see more broadbased growth across sectors, with valuations still ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A federal bankruptcy judge in Houston on Monday rejected Johnson & Johnson’s request to approve a $9 billion settlement with ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Class B shares of the right-leaning media outlet Newsmax (NYSE: NMAX) have blasted more than 1,123% higher since its initial public offering on March 31. Today, there is no sign of slowing, and this ...